Should You Buy Injective in 2025?

Why trust HelloSafe?

At HelloSafe, our expert has been closely monitoring the evolution of the Injective cryptocurrency for over three years. Every month, hundreds of thousands of users in Singapore rely on us to analyze market trends and identify the best investment opportunities. Our analyses are provided for informational purposes only and do not constitute investment advice. In line with our ethical guidelines, HelloSafe has never purchased Injective or received any compensation from entities related to its ecosystem.

Injective in brief

How much does 1 Injective cost?

The price of Injective is on the rise this week. As of today, INJ is trading at approximately S$17.46, up 6.77% in the past 24 hours and showing a stable trend over the week. Its market capitalisation stands at about S$1.72 billion, with an average three-month trading volume near S$130 million. Injective currently ranks 47th among all cryptocurrencies, with around 99 million INJ tokens in circulation and a market dominance of 0.12%. With notable price movements and an active ecosystem, INJ attracts both risk-aware and growth-seeking investors in Singapore’s dynamic crypto market.

Our complete review of the cryptocurrency Injective

Have we truly measured the momentum shift of Injective over the past three years? Our proprietary algorithms have parsed the latest on-chain metrics, technical signals, and shifting market structures—triangulating with competitive intelligence to deliver this focused review. So, why could 2025 see Injective return as a strategic entry point in the Layer 1 DeFi ecosystem?

Recent Performance and Market Context

Price Evolution

Injective (INJ) has experienced pronounced price swings, consolidating from its late-2023 all-time highs to a current value of ~$12.96 (as of 8 June 2025). After a major run-up in 2024, fluctuating between $30 and $45, INJ retraced alongside the broader altcoin market. However, this period has also marked the formation of a mid-term price floor near $10.90—a zone repeatedly confirmed as robust support during market corrections. Intraday volatility remains elevated (+6.77% over 24h), indicating persistent trading interest and reflecting healthy liquidity.

Recent Positive Events

• BitGo integration as an institutional validator (June 2025), bolstering Injective’s credibility with large-scale investors.
• CW-404 standard launch with DojoSwap, driving innovation in Layer 1 asset interoperability and composability.
• Expanding Ethereum DeFi integrations and a major Layer-2 technical upgrade signal deepening connectivity with the broader digital assets ecosystem.

Macro and Sector Tailwinds

On a macro scale, regulatory clarity in key markets (notably APAC and EMEA) and institutional capital flows into select DeFi verticals help underpin sector confidence. The rotation of capital into Layer 1 protocols with demonstrable adoption and TVL growth—Injective included—mirrors evolving investor risk appetites in 2025.

Technical Analysis

Core Crypto Indicators

• RSI (Relative Strength Index): 57.64, in neutral territory but approaching a bullish zone, suggesting latent upside momentum as oversold conditions resolve.
• Moving Averages: The short-term trend has faced downward pressure, yet long-term MAs suggest stabilisation, with potential crossovers indicating a trend reversal if bullish volume persists.
• Key Support Levels: $10.90, $10.43, and $9.63—historically defended by buyers, anchoring downside risk.
• Resistance: $14.16 is the immediate upside cap; a sustained break above could activate a new momentum phase.

Structure and Momentum

Price structure reveals strong accumulation in the $10–13 area, while a rebound above $14.16 would mark a technical breakout. On-chain flows echo rising exchange withdrawals, reducing available float and often signalling long-term holder conviction. The stage is set for a renewed rally should positive sectoral catalysts persist.

Fundamental Analysis

Adoption, Partnerships, Ecosystem

• Rapid dApp Growth: The expansion of the Injective ecosystem—especially in DeFi derivatives and multi-chain asset trading—augments its use cases.
• Strategic Partnerships: Collaborations with established players like BitGo and DojoSwap reinforce institutional buy-in.
• Developer Activity: Frequent technical upgrades (notably the Layer-2 roadmap) and community hackathons fuel innovation.

Attractive Relative Valuation

• Market Cap: ~$1.28 billion—attractive compared to Layer 1 peers with similar TVL and on-chain activity.
• Fully Diluted Valuation (FDV): Constrained due to a low remaining inflation schedule (100M total supply; ~98–99.97M circulating).
• TVL: ~$30 million (+22.52% over 24h) combined with $80M+ daily perpetual volume highlight sticky DeFi user engagement.
• Staking: 10% yield incentivizes long-term participation and token scarcity through active lockup.

Core Strengths

• True Layer 1 Interoperability: Built on Cosmos SDK, Injective enables seamless cross-chain flows (notably into Ethereum).
• On-chain Governance: Transparent, weighted voting aligns incentives and decentralises decision making.
• Deflationary Mechanics: Over $112 million worth of tokens burned, reducing supply and supporting long-term price.

Volume and Liquidity

• High 24h Volume: ~$97.9 million. This liquidity ensures tight spreads and institutional accessibility.
• Market Positioning: Regularly featured among top-100 crypto assets by cap and DeFi TVL rankings.

Catalysts and Positive Outlook

• Protocol Upgrades: Continuous technical enhancements and anticipated Layer 2 integrations widen scalability.
• Institutional Adoption: Validator set expansion and custodial partnerships bode well for capital inflows.
• Regulatory Clarity: Jurisdictions like Singapore and Hong Kong signal DeFi openness, facilitating new user segments.
• New Use Cases: Cross-chain derivatives and forex markets expand TAM (Total Addressable Market).

Investment Strategies (By Horizon)

Short-Term

• Reactivity to Upgrades/Event-Driven Moves: Entering on technical pullbacks near strong supports ($10.90–$12) or in anticipation of protocol announcements can harness volatility for tactical gains.

Medium-Term

• Building Exposure on Reversals: Ride potential breakout moves above $14.16, with catalysts from new DeFi suite launches or institutional news amplifying upside.

Long-Term

• Core Accumulation: For those targeting the ongoing evolution of the DeFi sector, the combination of scarcity, yield (staking), and aggressive ecosystem expansion justifies a core holding. Price mean-reversion to past highs ($30–$45) remains within scope should broader adoption play out.

Optimal positioning may involve staged entries—averaging in on technical dips and adjusting based on progress against the Layer 2 and cross-chain roadmap.

Injective Price Forecast Table

Is Now the Right Time to Consider Injective?

Injective is demonstrating a convergence of technical resilience and fundamental momentum rarely seen in mid-cap Layer 1s—anchored by clear product-market fit, a committed builder community, and high-value partnerships. With protocol upgrades, institutional validation, and an inventive DeFi stack on the horizon, the outlook for INJ appears distinctly favorable.

The current trading zone coincides with high-conviction accumulation, offering an appealing risk-reward profile for disciplined investors. Several leading indicators and upcoming catalysts underscore why Injective could be well positioned for a fresh bullish cycle. In this context, the evolving narrative around its ecosystem—and the robust five-year growth projections—suggest that INJ justifies renewed attention for those seeking exposure to the most dynamic corners of the digital asset space.

Injective remains a high-volatility cryptocurrency offering dynamic investment opportunities, though prudent risk management is required as always. The recent price acceleration demonstrates Injective's ability to generate swift and powerful moves, but evolving macro conditions demand selectivity. Key technical levels to monitor are $10.90 as immediate support and $14.16 as major resistance. The next scheduled protocol upgrade in Q2 2025 could be a pivotal catalyst for Injective's future trajectory.

How to buy Injective?

It is simple and secure to buy Injective (INJ) online from Singapore through a regulated crypto trading platform. You have two main options: a direct spot purchase, meaning you own and store the coins yourself, or trading via crypto CFDs (Contract for Difference), where you speculate on INJ price movements without owning the asset. Spot buying suits investors who want real tokens, while CFDs offer leveraged exposure with no wallet needed. Each approach has its own advantages, fees, and risks—a detailed comparison of leading platforms is provided further down this page.

Spot Purchase

A spot purchase means you really acquire INJ tokens, which you can hold in your personal wallet or leave on the platform. The most common fee is a fixed transaction commission, usually deducted in SGD or USD. For example, with the INJ current price at about USD 12.96 (approx. SGD 17.40), a SGD 1,400 investment (roughly USD 1,000) lets you buy around 77 INJ coins (SGD 1,400 ÷ SGD 17.40 = ~80, minus fees). With about SGD 7 in transaction fees, you would actually receive about 77 INJ.

Gain scenario

Gain scenario: If INJ rises by 10%, your holding is now worth about SGD 1,540. That’s a +SGD 140 gain, or +10% on your investment.

Trading via CFD

Trading Injective via CFD means you do not own the INJ coins themselves. Instead, you open a contract with a broker to speculate on the price, which you can trade with leverage. Fees include a spread (the difference between buy and sell prices) plus “overnight” financing fees if you keep your position open for more than a day. For example, with SGD 1,400 and 5x leverage, your market exposure is SGD 7,000.

Gain scenario

Gain scenario: If INJ moves up 8%, you earn 8% × 5 = 40% return. That’s +SGD 560 (on your SGD 1,400 margin, excluding fees).

Final Tip

Always compare the fees and trading conditions between available platforms before investing. Your choice should depend on your goals, risk tolerance, and prior experience in crypto investing. For more guidance, see the platform comparison table further below on this page.

Our 7 tips for buying Injective

The latest news from Injective

Injective integrates BitGo as an institutional validator, strengthening institutional-grade asset custody for Singaporean investors. This partnership, announced in early June 2025, marks a significant leap in security and institutional adoption for the Injective ecosystem. BitGo has a notable footprint serving Singaporean financial institutions and corporate clients, and its integration as a validator is likely to enhance confidence among local wealth managers and digital asset custodians. The move facilitates more secure staking and governance participation directly on Injective, potentially driving higher inflows from Singapore-based professional investors while tightening compliance and asset segregation—two key factors in the Singaporean regulatory landscape.

Injective’s Total Value Locked (TVL) surges 22% in 24 hours, signalling increased DeFi engagement in the Asia-Pacific region. Since the start of June, Injective’s TVL has jumped to approximately $30 million, fuelled by growing liquidity and a resurgence in DeFi trading volumes. This spike correlates with Asia-Pacific trading hours, and regional market participants—including those in Singapore—are increasingly exploring derivatives and cross-chain DeFi solutions as local platforms expand their support for INJ. The healthy uptick in staking (now over 51 million INJ staked) points to robust community engagement, with Singapore’s active crypto investor base contributing materially to this growth.

INJ maintains healthy trading volumes and is well-supported on leading Singaporean exchanges such as Crypto.com and Binance SG. Average 24-hour trading volumes for INJ reached nearly $98 million, a level sustained in part by strong activity on Asia-facing platforms. Notably, Singaporean users can access INJ pairs with high liquidity and local fiat on/off ramps, lowering barriers for both institutional and retail participants. This broad accessibility, combined with regulated local exchanges, positions INJ as an attractive asset for portfolio diversification among Singaporean investors seeking exposure to DeFi infrastructure tokens.

Technical upgrades and new DeFi integrations, including the CW-404 standard, expand utility and interoperability for Singapore’s crypto dev ecosystem. Recent ecosystem developments—most notably the launch of the CW-404 token standard via partnership with DojoSwap and continued integration with Ethereum-DeFi environments—are empowering global and regional builders. Singapore, a hub for blockchain innovation, stands to benefit from these advances as they lower entry barriers for local developers building on Injective, and facilitate cross-chain deployment strategies tailored to institutional and enterprise use cases.

Positive market sentiment and neutral technical momentum underline investor confidence amid Singapore’s supportive regulatory environment. With an RSI near 58 and a +6.77% price increase over 24 hours, technicals for INJ reflect a neutral-to-positive stance. Expert commentary in regional crypto finance media points to Singapore’s progressive regulatory clarity as a tailwind for continued adoption and market stability. Singaporean analysts cite INJ’s clear governance framework, credible leadership (Eric Chen, Albert Chon), and the protocol’s deflationary tokenomics as supporting factors for medium-term appreciation potential and constructive sentiment within the local crypto investment community.

FAQ

P. Laurore

Finance expert

Co-founder of HelloSafe and holder of a Master's degree in finance, Pauline has recognised expertise in personal finance, which she uses to help users better understand and optimise their financial choices. At HelloSafe, Pauline plays a key role in designing clear, educational content on savings, investments and personal finance. Passionate about financial education, Pauline strives, with every piece of content she oversees, to provide reliable, transparent and unbiased information for independent and informed financial management. To this end, she has tested over 100 trading platforms to help internet users make the right choices.